Recent Updates
Recently added Catalysts
KYMR Positive Sentiment Score: 65/100

Kymera Therapeutics to Report Third Quarter 2025 Financial Results on November 4, 2025

Tuesday, October 28, 2025 1 min read
Key Takeaway: Kymera Therapeutics, a clinical-stage biopharmaceutical company, is set to report its financial results for the third quarter of 2025 on November 4, 2025. This report will be accompanied by a video conference call scheduled for 8:30 a.m. ET, allowing stakeholders to engage directly with the company. The results will offer insights into the company's performance and developments in their innovative degrader medicines.

Market Sentiment Analysis

POSITIVE FACTORS

  • Kymera Therapeutics is advancing a new class of oral small molecule degrader medicines.
  • The announcement of financial results indicates ongoing business activity and transparency.
  • The upcoming video conference call provides investors an opportunity for engagement.

Full Press Release Details

WATERTOWN, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, will report third quarter 2025 financial results on November 4, 2025. The Company will host a video conference call and webcast at 8:30 a.m. ET that day.
To join the video call or view the livestreamed webcast, please register via this link, or visit “News and Events” in the Investors section of the Company’s website at www.kymeratx.com. A replay of the webcast will be archived and available following the event.
About Kymera Therapeutics

Tags

Targeted Protein Degradation

Frequently Asked Questions

When will Kymera Therapeutics report its Q3 2025 results?

Kymera Therapeutics will announce its Q3 2025 financial results on November 4, 2025.

What time is the Kymera Therapeutics video conference call?

The video conference call will be held at 8:30 a.m. ET on November 4, 2025.

How can I view the Kymera Therapeutics webcast?

You can register or view the webcast through the Investors section on their website.

Will there be a replay of the Kymera Therapeutics webcast?

Yes, a replay of the webcast will be available after the event.

What type of medicines does Kymera Therapeutics develop?

Kymera Therapeutics develops oral small molecule degrader medicines for immunological diseases.

Tags: KYMR Viatris Investor Conferences Healthcare Kymera Therapeutics biopharmaceutical Q3 2025 financial results
Last updated: Oct 28, 2025